Oncolytics Biotech Inc (NAS:ONCY)
$ 0.97 0 (0%) Market Cap: 75.59 Mil Enterprise Value: 62.70 Mil PE Ratio: 0 PB Ratio: 10.78 GF Score: 31/100

Q1 2021 Oncolytics Biotech Inc Earnings Call and Annual Corporate Update Transcript

May 07, 2021 / 04:10PM GMT
Release Date Price: $2.86 (-2.05%)
Kirk J. Look
Oncolytics Biotech Inc. - CFO

Good afternoon, and welcome to the Annual Meeting of Shareholders of Oncolytics Biotech Inc. My name is Kirk Look, and I'm the Chief Financial Officer of Oncolytics, and I will be serving as Chair of this meeting. Joining me today is Matt Coffey, President and CEO; as well, we have Wayne Pisano, Deborah Brown, Angela Holtham, Leon Kruimer, Bernd Seizinger and Bill Rice, who, I believe, have joined us online. Other members of management also joining us online are Allison Hagerman, Andrew de Guttadauro and Tom Heineman.

Now for convenience, we have divided today's meeting into 2 parts. (technical difficulty) After we conclude the formal part of the meeting, we will provide a brief corporate update with a general Q&A at the end.

Before we begin with the formal business portion of the meeting, I will provide some comments on voting and questions at today's meeting. Now as with any technology, unexpected glitches may occur and we appreciate your patience. Our service providers for this platform at Lumi and AST are very experienced at running

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot